vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and EASTGROUP PROPERTIES INC (EGP). Click either name above to swap in a different company.

EASTGROUP PROPERTIES INC is the larger business by last-quarter revenue ($190.3M vs $121.8M, roughly 1.6× Core Laboratories Inc.). EASTGROUP PROPERTIES INC runs the higher net margin — 49.7% vs 4.2%, a 45.5% gap on every dollar of revenue. On growth, EASTGROUP PROPERTIES INC posted the faster year-over-year revenue change (9.1% vs -1.4%). EASTGROUP PROPERTIES INC produced more free cash flow last quarter ($126.7M vs $517.0K). Over the past eight quarters, EASTGROUP PROPERTIES INC's revenue compounded faster (9.4% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Genpact Ltd. is an American information technology services, consulting, and outsourcing company headquartered in New York City, New York. Founded in Gurgaon, India, and legally domiciled in Bermuda, Genpact employs more than 125,000 people and provides services to clients in over 30 countries worldwide. Genpact is listed on the NYSE and generated revenues of US$4.48 billion in 2023.

CLB vs EGP — Head-to-Head

Bigger by revenue
EGP
EGP
1.6× larger
EGP
$190.3M
$121.8M
CLB
Growing faster (revenue YoY)
EGP
EGP
+10.5% gap
EGP
9.1%
-1.4%
CLB
Higher net margin
EGP
EGP
45.5% more per $
EGP
49.7%
4.2%
CLB
More free cash flow
EGP
EGP
$126.2M more FCF
EGP
$126.7M
$517.0K
CLB
Faster 2-yr revenue CAGR
EGP
EGP
Annualised
EGP
9.4%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLB
CLB
EGP
EGP
Revenue
$121.8M
$190.3M
Net Profit
$5.1M
$94.6M
Gross Margin
Operating Margin
1.5%
Net Margin
4.2%
49.7%
Revenue YoY
-1.4%
9.1%
Net Profit YoY
59.2%
EPS (diluted)
$0.11
$1.77

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
EGP
EGP
Q1 26
$121.8M
$190.3M
Q4 25
$138.3M
$187.5M
Q3 25
$134.5M
$182.1M
Q2 25
$130.2M
$177.3M
Q1 25
$123.6M
$174.4M
Q4 24
$129.2M
$164.0M
Q3 24
$134.4M
$162.9M
Q2 24
$130.6M
$159.1M
Net Profit
CLB
CLB
EGP
EGP
Q1 26
$5.1M
$94.6M
Q4 25
$4.9M
$67.8M
Q3 25
$14.2M
$67.0M
Q2 25
$10.6M
$63.3M
Q1 25
$-154.0K
$59.4M
Q4 24
$7.4M
$58.7M
Q3 24
$11.7M
$55.2M
Q2 24
$9.0M
$55.3M
Gross Margin
CLB
CLB
EGP
EGP
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
EGP
EGP
Q1 26
1.5%
Q4 25
11.5%
Q3 25
15.6%
Q2 25
11.7%
Q1 25
3.6%
Q4 24
11.0%
Q3 24
14.7%
Q2 24
12.3%
Net Margin
CLB
CLB
EGP
EGP
Q1 26
4.2%
49.7%
Q4 25
3.6%
36.1%
Q3 25
10.6%
36.8%
Q2 25
8.2%
35.7%
Q1 25
-0.1%
34.1%
Q4 24
5.7%
35.8%
Q3 24
8.7%
33.9%
Q2 24
6.9%
34.8%
EPS (diluted)
CLB
CLB
EGP
EGP
Q1 26
$0.11
$1.77
Q4 25
$0.11
$1.27
Q3 25
$0.30
$1.26
Q2 25
$0.22
$1.20
Q1 25
$0.00
$1.14
Q4 24
$0.15
$1.17
Q3 24
$0.25
$1.13
Q2 24
$0.19
$1.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
EGP
EGP
Cash + ST InvestmentsLiquidity on hand
$22.8M
$31.4M
Total DebtLower is stronger
$1.6B
Stockholders' EquityBook value
$275.1M
$3.6B
Total Assets
$587.7M
$5.5B
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
EGP
EGP
Q1 26
$22.8M
$31.4M
Q4 25
$22.7M
$1.0M
Q3 25
$25.6M
$3.0M
Q2 25
$31.2M
$32.9M
Q1 25
$22.1M
$20.5M
Q4 24
$19.2M
$17.5M
Q3 24
$21.5M
$17.0M
Q2 24
$17.7M
$39.4M
Total Debt
CLB
CLB
EGP
EGP
Q1 26
$1.6B
Q4 25
$110.3M
Q3 25
$114.1M
$1.4B
Q2 25
$124.6M
$1.5B
Q1 25
$124.4M
$1.5B
Q4 24
$126.1M
$1.5B
Q3 24
$139.9M
$1.6B
Q2 24
$147.6M
$1.7B
Stockholders' Equity
CLB
CLB
EGP
EGP
Q1 26
$275.1M
$3.6B
Q4 25
$266.0M
$3.5B
Q3 25
$271.3M
$3.5B
Q2 25
$261.3M
$3.4B
Q1 25
$253.4M
$3.3B
Q4 24
$246.6M
$3.3B
Q3 24
$250.7M
$2.8B
Q2 24
$240.3M
$2.8B
Total Assets
CLB
CLB
EGP
EGP
Q1 26
$587.7M
$5.5B
Q4 25
$584.0M
$5.4B
Q3 25
$591.4M
$5.4B
Q2 25
$602.1M
$5.2B
Q1 25
$591.5M
$5.1B
Q4 24
$585.1M
$5.1B
Q3 24
$600.5M
$4.8B
Q2 24
$597.8M
$4.7B
Debt / Equity
CLB
CLB
EGP
EGP
Q1 26
0.45×
Q4 25
0.41×
Q3 25
0.42×
0.41×
Q2 25
0.48×
0.43×
Q1 25
0.49×
0.43×
Q4 24
0.51×
0.46×
Q3 24
0.56×
0.57×
Q2 24
0.61×
0.60×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
EGP
EGP
Operating Cash FlowLast quarter
$4.0M
$142.3M
Free Cash FlowOCF − Capex
$517.0K
$126.7M
FCF MarginFCF / Revenue
0.4%
66.6%
Capex IntensityCapex / Revenue
8.2%
Cash ConversionOCF / Net Profit
0.77×
1.50×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$771.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
EGP
EGP
Q1 26
$4.0M
$142.3M
Q4 25
$7.9M
$480.7M
Q3 25
$8.5M
$138.9M
Q2 25
$13.9M
$143.4M
Q1 25
$6.7M
$133.7M
Q4 24
$20.6M
$416.6M
Q3 24
$13.1M
$122.9M
Q2 24
$17.1M
$122.9M
Free Cash Flow
CLB
CLB
EGP
EGP
Q1 26
$517.0K
$126.7M
Q4 25
$5.0M
$404.9M
Q3 25
$6.5M
$120.3M
Q2 25
$10.4M
$119.2M
Q1 25
$3.9M
$113.9M
Q4 24
$17.4M
$357.3M
Q3 24
$10.4M
$108.5M
Q2 24
$14.3M
$102.8M
FCF Margin
CLB
CLB
EGP
EGP
Q1 26
0.4%
66.6%
Q4 25
3.6%
216.0%
Q3 25
4.8%
66.0%
Q2 25
8.0%
67.2%
Q1 25
3.1%
65.3%
Q4 24
13.4%
217.8%
Q3 24
7.7%
66.6%
Q2 24
10.9%
64.6%
Capex Intensity
CLB
CLB
EGP
EGP
Q1 26
8.2%
Q4 25
2.1%
40.5%
Q3 25
1.5%
10.2%
Q2 25
2.7%
13.7%
Q1 25
2.3%
11.3%
Q4 24
2.5%
36.1%
Q3 24
2.0%
8.9%
Q2 24
2.2%
12.6%
Cash Conversion
CLB
CLB
EGP
EGP
Q1 26
0.77×
1.50×
Q4 25
1.61×
7.10×
Q3 25
0.60×
2.07×
Q2 25
1.31×
2.26×
Q1 25
2.25×
Q4 24
2.78×
7.10×
Q3 24
1.12×
2.23×
Q2 24
1.90×
2.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons